4 Patents
- US123369882025Therapeutic Targeting of KMT2D Mutant Lung Squamous Cell Carcinoma Through RTK-RAS Signaling Inhibition
NEW YORK UNIVERSITY
0 cites - 0 cites
- US118651762024Compositions and Methods of Modulating Anti-tumor Immunity
Dana-farber Cancer Institute, Inc.
0 cites - US116240932023Tumor Suppressor and Oncogene Biomarkers Predictive of Anti-immune Checkpoint Inhibitor Response
Children's Medical Center Corporation
0 cites